# Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

> **NCT00362479** · PHASE3 · COMPLETED · sponsor: **Duramed Research** · enrollment: 1347 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** DR-1021

## Key facts

- **NCT ID:** NCT00362479
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 1347 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00362479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00362479, "Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00362479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*